Yifan Pharmaceutical Co., Ltd. (002019.SZ)
CNY 11.38
(0.53%)
CNY 11.38
(0.53%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 812.04 Million CNY | -12.76% |
| 2022 | 930.86 Million CNY | 13.48% |
| 2021 | 820.3 Million CNY | 83.26% |
| 2020 | 447.62 Million CNY | 433.1% |
| 2019 | 83.96 Million CNY | 160.8% |
| 2018 | 32.19 Million CNY | -74.04% |
| 2017 | 124 Million CNY | -31.11% |
| 2016 | 180 Million CNY | 500.0% |
| 2015 | 30 Million CNY | 2999999900.0% |
| 2014 | 1.00 CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| 2011 | - CNY | -100.0% |
| 2010 | 80 Million CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| 2004 | - CNY | -100.0% |
| 2003 | 30 Million CNY | 0.0% |
| 2002 | - CNY | 0.0% |
| 2001 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 674.65 Million CNY | -5.95% |
| 2024 Q1 | 717.36 Million CNY | -11.66% |
| 2024 Q3 | 703.84 Million CNY | 4.33% |
| 2023 FY | 812.04 Million CNY | -12.76% |
| 2023 Q2 | 965.69 Million CNY | -10.29% |
| 2023 Q3 | 800.57 Million CNY | -17.1% |
| 2023 Q4 | 812.04 Million CNY | 1.43% |
| 2023 Q1 | 1.07 Billion CNY | 15.65% |
| 2022 Q1 | 789.99 Million CNY | -3.7% |
| 2022 Q3 | 1.11 Billion CNY | -1.18% |
| 2022 FY | 930.86 Million CNY | 13.48% |
| 2022 Q2 | 1.12 Billion CNY | 42.35% |
| 2022 Q4 | 930.86 Million CNY | -16.23% |
| 2021 Q1 | 868.29 Million CNY | 93.98% |
| 2021 Q4 | 820.3 Million CNY | 40.08% |
| 2021 FY | 820.3 Million CNY | 83.26% |
| 2021 Q2 | 625.03 Million CNY | -28.02% |
| 2021 Q3 | 585.59 Million CNY | -6.31% |
| 2020 Q3 | 432.27 Million CNY | 2.04% |
| 2020 Q1 | 173.75 Million CNY | 106.94% |
| 2020 FY | 447.62 Million CNY | 433.1% |
| 2020 Q2 | 423.61 Million CNY | 143.8% |
| 2020 Q4 | 447.62 Million CNY | 3.55% |
| 2019 Q4 | 83.96 Million CNY | 337.49% |
| 2019 Q3 | 19.19 Million CNY | 19.13% |
| 2019 FY | 83.96 Million CNY | 160.8% |
| 2019 Q1 | 32.15 Million CNY | -0.13% |
| 2019 Q2 | 16.11 Million CNY | -49.9% |
| 2018 Q4 | 32.19 Million CNY | -32.93% |
| 2018 Q1 | 124 Million CNY | 0.0% |
| 2018 FY | 32.19 Million CNY | -74.04% |
| 2018 Q2 | 48 Million CNY | -61.29% |
| 2018 Q3 | 48 Million CNY | 0.0% |
| 2017 FY | 124 Million CNY | -31.11% |
| 2017 Q3 | 120 Million CNY | 0.0% |
| 2017 Q2 | 120 Million CNY | -33.33% |
| 2017 Q1 | 180 Million CNY | 0.0% |
| 2017 Q4 | 124 Million CNY | 3.33% |
| 2016 FY | 180 Million CNY | 500.0% |
| 2016 Q1 | 30 Million CNY | 0.0% |
| 2016 Q2 | 270 Million CNY | 800.0% |
| 2016 Q4 | 180 Million CNY | -25.0% |
| 2016 Q3 | 240 Million CNY | -11.11% |
| 2015 Q4 | 30 Million CNY | -25.0% |
| 2015 Q3 | 40 Million CNY | 0.0% |
| 2015 Q2 | 40 Million CNY | 0.0% |
| 2015 Q1 | - CNY | -100.0% |
| 2015 FY | 30 Million CNY | 2999999900.0% |
| 2014 Q4 | 1.00 CNY | 0.0% |
| 2014 Q3 | - CNY | 0.0% |
| 2014 Q1 | - CNY | 0.0% |
| 2014 Q2 | - CNY | 0.0% |
| 2014 FY | 1.00 CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2013 Q4 | - CNY | 0.0% |
| 2013 Q3 | - CNY | 0.0% |
| 2013 Q2 | - CNY | 0.0% |
| 2013 Q1 | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |
| 2012 Q2 | - CNY | 0.0% |
| 2012 Q4 | - CNY | 0.0% |
| 2012 Q3 | - CNY | 0.0% |
| 2012 Q1 | - CNY | 0.0% |
| 2011 Q2 | 80 Million CNY | 0.0% |
| 2011 Q4 | - CNY | -100.0% |
| 2011 Q3 | 80 Million CNY | 0.0% |
| 2011 Q1 | 80 Million CNY | 0.0% |
| 2011 FY | - CNY | -100.0% |
| 2010 Q2 | 80 Million CNY | 0.0% |
| 2010 Q4 | 80 Million CNY | 0.0% |
| 2010 Q3 | 80 Million CNY | 0.0% |
| 2010 FY | 80 Million CNY | 0.0% |
| 2010 Q1 | - CNY | 0.0% |
| 2009 Q1 | - CNY | 0.0% |
| 2009 Q4 | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2009 Q2 | - CNY | 0.0% |
| 2009 Q3 | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2008 Q3 | - CNY | 0.0% |
| 2008 Q2 | - CNY | 0.0% |
| 2008 Q1 | - CNY | 0.0% |
| 2008 Q4 | - CNY | 0.0% |
| 2007 Q2 | - CNY | 0.0% |
| 2007 Q1 | - CNY | 0.0% |
| 2007 Q3 | - CNY | 0.0% |
| 2007 Q4 | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 Q1 | - CNY | 0.0% |
| 2006 Q3 | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2006 Q4 | - CNY | 0.0% |
| 2006 Q2 | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |
| 2005 Q1 | - CNY | 0.0% |
| 2005 Q2 | - CNY | 0.0% |
| 2005 Q3 | - CNY | 0.0% |
| 2005 Q4 | - CNY | 0.0% |
| 2004 FY | - CNY | -100.0% |
| 2004 Q3 | - CNY | -100.0% |
| 2004 Q2 | 30 Million CNY | 0.0% |
| 2004 Q4 | - CNY | 0.0% |
| 2003 FY | 30 Million CNY | 0.0% |
| 2003 Q4 | 30 Million CNY | 0.0% |
| 2002 FY | - CNY | 0.0% |
| 2001 FY | - CNY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Zhejiang Int'l Group Co.,Ltd. | 671.68 Million CNY | -20.897% |
| Zhejiang Zhenyuan Share Co., Ltd. | 54.96 Million CNY | -1377.492% |
| Hunan Jingfeng Pharmaceutical Co.,Ltd. | 94.96 Million CNY | -755.067% |
| Hubei Guangji Pharmaceutical Co., Ltd. | 419.53 Million CNY | -93.557% |
| Guangdong Jiaying Pharmaceutical Co., Ltd | - CNY | -Infinity% |
| Sichuan Kelun Pharmaceutical Co., Ltd. | 2.64 Billion CNY | 69.341% |
| Chongqing Lummy Pharmaceutical Co., Ltd. | 126.5 Million CNY | -541.931% |
| Boai NKY Medical Holdings Ltd. | 32.61 Million CNY | -2389.82% |
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. | 21.25 Million CNY | -3720.278% |